|
|
|
|
|
by Stupulous
1258 days ago
|
|
As a depression treatment, it far exceeds the state-of-the-art SSRIs, which perform only slightly better than placebo. It's cheaper, more effective, and lasts longer. ~10% of Americans suffer from depression, and more than a third of them don't respond to SSRIs at all. Dramatically reducing the suffering of 3% of the population at net-negative cost is a big deal. For comparison to topics-de-jour, in the US 0.3% of the population will get an abortion in a given year, 3.5% are gay/bi, 0.3% are trans, <0.03% die from gun violence (and over half are suicides potentially reduced by this treatment) each year, and about 1/40th of them are killed by law enforcement. Improvements in these areas will have a smaller effect size (ie. protecting gay marriage will not improve the lives of gay people as much as curing someone's depression will, gun control will not end all gun violence). Big caveat here is that this treatment is relatively new, and depression treatments tend to be promising initially with results that fade in the long term. Additionally, the legalization of that treatment does not mean everyone who needs it will get it. On the other hand, depression is only one of the many issues that can be treated with psychadelics. We'll have to wait and see |
|